Back to Top
Tanfanercept Biosimilar - Research Grade
$710.00 - $6,900.00
Tanfanercept Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
TNF-_ receptor I [Homo sapiens]
Concentration
5mg/ml
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Tumor necrosis factor signaling through TNF receptor I drives inflammation across many autoimmune disease models. This research-grade product is a non-therapeutic analog of tanfanercept, a recombinant TNF-receptor fusion protein rather than a conventional antibody, offered strictly for research use only. It is manufactured to in vivo standards in a low-endotoxin format and produced in scalable milligram to gram quantities for heavy-usage and high-throughput laboratories. The reagent acts as a soluble decoy in TNF-neutralization functional assays, in vitro cytokine-signaling screens, and in vivo models of inflammatory disease. Reliable batch-to-batch consistency helps standardize comparisons across in vitro and in vivo experiments.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












